Alternatively, PPM1D can be stabilized in tumor cells by mutations in the regulatory domain, which, similar to amplification of the gene, affects tumorigenesis [47] and resistance to anticancer therapy [48]. The gene discussed is PPM1D; the disease is neoplasm.